Lista de obras -

21-Gene expression profile assay on core needle biopsies predicts responses to neoadjuvant endocrine therapy in breast cancer patients.

artículo científico publicado en 2009

A Phase II Study of Modified FOLFOX6 for Advanced Gastric Cancer Refractory to Standard Therapies

scientific article published on 07 May 2020

A multi-institutional phase II trial of paclitaxel and carboplatin in the treatment of advanced or recurrent cervical cancer

artículo científico publicado en 2012

A pilot feasibility study for cisplatin plus S-1 for the treatment for advanced or recurrent cervical cancer

artículo científico publicado en 2013

A retrospective study of the impact of age on patterns of care for elderly patients with metastatic breast cancer.

artículo científico publicado en 2010

Acute hyperammonemic encephalopathy after fluoropyrimidine-based chemotherapy: A case series and review of the literature

artículo científico publicado en 2017

An alternative medicine, Agaricus blazei, may have induced severe hepatic dysfunction in cancer patients

artículo científico publicado en 2006

Analysis of the clinicopathological prognosis of stage IVb cervical carcinoma

scientific article published on 01 February 2008

Assessment of different criteria for the pathological complete response (pCR) to primary chemotherapy in breast cancer: standardization is needed

artículo científico publicado en 2008

Baseline Sarcopenia and Skeletal Muscle Loss During Chemotherapy Affect Survival Outcomes in Metastatic Gastric Cancer

artículo científico publicado en 2018

Brain metastases in patients who receive trastuzumab-containing chemotherapy for HER2-overexpressing metastatic breast cancer

artículo científico publicado en 2009

Cancer of unknown primary site: review of consecutive cases at the National Cancer Center Hospital of Japan

artículo científico publicado en 2006

Clinical efficacy of S-1 in pretreated metastatic breast cancer patients

artículo científico publicado en 2008

Clinical outcomes of adult and childhood rhabdomyosarcoma treated with vincristine, d-actinomycin, and cyclophosphamide chemotherapy

artículo científico publicado en 2012

Clinicopathological features of tumors as predictors of the efficacy of primary neoadjuvant chemotherapy for operable breast cancer

artículo científico publicado en 2009

Comparison among different classification systems regarding the pathological response of preoperative chemotherapy in relation to the long-term outcome

artículo científico publicado en 2008

Comparison of dose intensity of vincristine, d-actinomycin, and cyclophosphamide chemotherapy for child and adult rhabdomyosarcoma: a retrospective analysis.

artículo científico publicado en 2012

Content analysis of oncology-related pharmaceutical advertising in a peer-reviewed medical journal

artículo científico publicado en 2012

Contrasting prognostic implications of platelet-derived growth factor receptor-β and vascular endothelial growth factor receptor-2 in patients with angiosarcoma.

artículo científico publicado en 2011

Correlation between human epidermal growth factor receptor 2 expression level and efficacy of trastuzumab beyond progression in metastatic gastric cancer ⬇️

artículo científico

Correlation of p53 and MIB-1 expression with both the systemic recurrence and survival in cases of phyllodes tumors of the breast

artículo científico publicado en 2006

Current state of therapeutic development for rare cancers in Japan, and proposals for improvement.

artículo científico publicado en 2018

Current trends and controversies over pre-operative chemotherapy for women with operable breast cancer

artículo científico publicado en 2007

Depth of response predicts the clinical outcome of advanced HER2-positive gastric cancer to trastuzumab-based first-line chemotherapy

artículo científico publicado en 2017

Development and verification of a prediction model using serum tumor markers to predict the response to chemotherapy of patients with metastatic or recurrent breast cancer

artículo científico publicado en 2008

Diagnosis of complete response to neoadjuvant chemotherapy using diagnostic imaging in primary breast cancer patients.

artículo científico publicado en 2005

Efficacy of Cytotoxic Agents After Progression on Anti-PD-(L)1 Antibody for Pre-treated Metastatic Gastric Cancer

scientific article published on 01 April 2020

Efficacy of Second-Line Bevacizumab-Containing Chemotherapy for Patients with Metastatic Colorectal Cancer following First-Line Treatment with an Anti-Epidermal Growth Factor Receptor Antibody

artículo científico publicado en 2017

Efficacy of everolimus, a novel mTOR inhibitor, against basal-like triple-negative breast cancer cells

artículo científico publicado en 2012

Efficacy of taxane regimens in patients with metastatic angiosarcoma

artículo científico publicado el 1 de julio de 2011

Efficacy of weekly paclitaxel in patients with docetaxel-resistant metastatic breast cancer

artículo científico publicado en 2005

Establishment and validation of prognostic nomograms in first-line metastatic gastric cancer patients.

artículo científico publicado en 2018

Expression of insulin-like growth factor 1 receptor in primary breast cancer: immunohistochemical analysis

artículo científico

FOLFOX as First-line Therapy for Gastric Cancer with Severe Peritoneal Metastasis

artículo científico publicado en 2017

Factors that affect the duration of the interval between the completion of palliative chemotherapy and death

artículo científico publicado en 2009

Favorable outcome in patients with breast cancer in the presence of pathological response after neoadjuvant endocrine therapy

scientific article published on 05 April 2007

Feasibility and usefulness of the 'Distress Screening Program in Ambulatory Care' in clinical oncology practice

artículo científico publicado en 2010

Gene expression profiling of ATP-binding cassette (ABC) transporters as a predictor of the pathologic response to neoadjuvant chemotherapy in breast cancer patients

artículo científico

Genetic testing for effective Herceptin therapy

artículo científico publicado en 2002

Hematologic safety of breast cancer chemotherapies in patients with hepatitis B or C virus infection

artículo científico publicado en 2012

Immunohistochemical expression of HER1, HER3, and HER4 in HER2-positive breast cancer patients treated with trastuzumab-containing neoadjuvant chemotherapy

artículo científico publicado en 2010

Immunohistochemical expression of PTEN and phosphorylated Akt are not correlated with clinical outcome in breast cancer patients treated with trastuzumab-containing neo-adjuvant chemotherapy

artículo científico publicado en 2008

Immunohistochemical profile for unknown primary adenocarcinoma

artículo científico publicado en 2012

Influence of suboptimal treatment in patients with mediastinal primary nonseminomatous germ cell tumors

artículo científico publicado en 2010

Leptomeningeal metastasis from ovarian carcinoma successfully treated by the intraventricular administration of methotrexate

artículo científico publicado en 2008

Long-term outcome and pattern of relapse after neoadjuvant chemotherapy in patients with human epidermal growth factor receptor 2-positive primary breast cancer.

artículo científico publicado en 2009

Long-term survival analysis of addition of carboplatin to neoadjuvant chemotherapy in HER2-negative breast cancer

scientific article published on 05 March 2020

Morphologic Response and Tumor Shrinkage as Early Predictive Markers in Unresectable Colorectal Liver Metastases

artículo científico publicado en 2018

Multicenter phase II trial assessing effectiveness of imatinib mesylate on relapsed or refractory KIT-positive or PDGFR-positive sarcoma

artículo científico publicado en 2010

Neutropenia as a Predictive Factor in Metastatic Colorectal Cancer Treated With TAS-102

scientific article published on 21 July 2016

Outpatient management of low-risk febrile patients on paclitaxel and carboplatin for ovarian cancer.

artículo científico publicado en 2009

Paclitaxel-induced peripheral neuropathy in patients receiving adjuvant chemotherapy for breast cancer

artículo científico publicado en 2011

Phase I Study of Alternate-Day Administration of S-1, Oral Leucovorin, and Bevacizumab for Refractory Metastatic Colorectal Cancer

artículo científico publicado en 2020

Phase I and pharmacokinetic study of nab-paclitaxel, nanoparticle albumin-bound paclitaxel, administered weekly to Japanese patients with solid tumors and metastatic breast cancer

artículo científico publicado en 2011

Phase I and pharmacokinetic study of trabectedin, a DNA minor groove binder, administered as a 24-h continuous infusion in Japanese patients with soft tissue sarcoma

artículo científico publicado en 2014

Phase I and pharmacokinetic study of trastuzumab emtansine in Japanese patients with HER2-positive metastatic breast cancer

artículo científico publicado en 2014

Prediction of response and prognostic factors for Ewing family of tumors in a low incidence population

artículo científico publicado en 2007

Prediction of response to repeat utilization of anthracycline in recurrent breast cancer patients previously administered anthracycline-containing chemotherapeutic regimens as neoadjuvant or adjuvant chemotherapy

artículo científico publicado en 2006

Primary yolk sac tumor of the omentum: a case report and literature review

artículo científico publicado en 2012

Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors

scientific article published on 29 November 2008

Prognostic factors in young Japanese women with breast cancer: prognostic value of age at diagnosis

scientific article published on 14 October 2010

Questionnaire survey of treatment choice for breast cancer patients with brain metastasis in Japan: results of a nationwide survey by the task force of the Japanese Breast Cancer Society

artículo científico publicado en 2008

Randomized phase II study of primary systemic chemotherapy and trastuzumab for operable HER2 positive breast cancer.

artículo científico publicado en 2011

Randomized phase II study of weekly paclitaxel with and without carboplatin followed by cyclophosphamide/epirubicin/5-fluorouracil as neoadjuvant chemotherapy for stage II/IIIA breast cancer without HER2 overexpression

artículo científico publicado en 2014

Randomized phase III trial of trastuzumab monotherapy followed by trastuzumab plus docetaxel versus trastuzumab plus docetaxel as first-line therapy in patients with HER2-positive metastatic breast cancer: the JO17360 Trial Group

artículo científico publicado en 2009

Regorafenib Versus Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: A Retrospective Comparison

artículo científico publicado en 2016

Relapse with malignant transformation after chemotherapy for primary mediastinal seminoma: case report.

artículo científico publicado en 2009

Safety and efficacy of a combination of docetaxel and cisplatin in patients with unknown primary cancer

artículo científico publicado en 2010

Salvage chemotherapy with the combination of oxaliplatin, leucovorin, and 5-fluorouracil in advanced gastric cancer refractory or intolerant to fluoropyrimidines, platinum, taxanes, and irinotecan.

artículo científico publicado en 2018

Second platinum therapy in patients with uterine cervical cancer previously treated with platinum chemotherapy

artículo científico publicado en 2010

Second-line chemotherapy in patients with primary unknown cancer.

artículo científico publicado en 2011

Serum CA19-9 Response Is an Early Predictive Marker of Efficacy of Regorafenib in Refractory Metastatic Colorectal Cancer

artículo científico publicado en 2017

Standardization of the body surface area (BSA) formula to calculate the dose of anticancer agents in Japan

artículo científico publicado en 2003

Successful Treatment of Cardiac Angiosarcoma Associated with Disseminated Intravascular Coagulation with Nab-Paclitaxel: A Case Report and Review of the Literature

artículo científico publicado en 2017

The impact of the Glasgow Prognostic Score on survival in second-line chemotherapy for metastatic colorectal cancer patients with V600E mutation

The incidence and management of metachronous testicular germ cell tumors in patients with extragonadal germ cell tumors

artículo científico publicado en 2010

The notorious "drug lag" for oncology drugs in Japan

scientific article published on February 2011

The outpatient management of low-risk febrile patients with neutropenia: risk assessment over the telephone.

artículo científico publicado en 2006

The use of contrast-enhanced computed tomography before neoadjuvant chemotherapy to identify patients likely to be treated safely with breast-conserving surgery

artículo científico publicado en 2004

Therapy-related acute promyelocytic leukemia caused by hormonal therapy and radiation in a patient with recurrent breast cancer

artículo científico publicado en 2008

Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer

artículo científico publicado en 2011

Tumor-marker analysis and verification of prognostic models in patients with cancer of unknown primary, receiving platinum-based combination chemotherapy

scientific article published on 22 June 2006

Unknown primary carcinoma: a feasibility assessment of combination chemotherapy with cisplatin and docetaxel

artículo científico publicado en 2003

Use of squamous cell carcinoma antigen as a biomarker of chemotherapy response in patients with metastatic cervical carcinoma

artículo científico publicado en 2011

Use of the neo-adjuvant exemestane in post-menopausal estrogen receptor-positive breast cancer: a randomized phase II trial (PTEX46) to investigate the optimal duration of preoperative endocrine therapy

artículo científico publicado en 2013

Usefulness of third-line chemotherapy for women with recurrent ovarian, fallopian tube, and primary peritoneal cancer who receive platinum/taxane regimens as first-line therapy

artículo científico publicado en 2008

Utility of Bayesian Single-Arm Design in New Drug Application for Rare Cancers in Japan: A Case Study of Phase 2 Trial for Sarcoma

artículo científico publicado en 2017

Weekly paclitaxel and carboplatin against advanced transitional cell cancer after failure of a platinum-based regimen.

artículo científico publicado en 2007

[A feasibility study of doxorubicin/cisplatin (AP) for postoperative chemotherapy in patients with advanced endometrial cancer]

artículo científico publicado en 2006

[Current topics of chemotherapy for sarcoma and bone neoplasms]

scientific article published on 01 March 2008

[Survey on oncologists-provided information on treatment-related infertility to breast cancer patients]

artículo científico publicado en 2012

Lista de obras de

21-Gene expression profile assay on core needle biopsies predicts responses to neoadjuvant endocrine therapy in breast cancer patients.

A Phase II Study of Modified FOLFOX6 for Advanced Gastric Cancer Refractory to Standard Therapies

A multi-institutional phase II trial of paclitaxel and carboplatin in the treatment of advanced or recurrent cervical cancer

A pilot feasibility study for cisplatin plus S-1 for the treatment for advanced or recurrent cervical cancer

A retrospective study of the impact of age on patterns of care for elderly patients with metastatic breast cancer.

Acute hyperammonemic encephalopathy after fluoropyrimidine-based chemotherapy: A case series and review of the literature

An alternative medicine, Agaricus blazei, may have induced severe hepatic dysfunction in cancer patients

Analysis of the clinicopathological prognosis of stage IVb cervical carcinoma

Assessment of different criteria for the pathological complete response (pCR) to primary chemotherapy in breast cancer: standardization is needed

Baseline Sarcopenia and Skeletal Muscle Loss During Chemotherapy Affect Survival Outcomes in Metastatic Gastric Cancer

Brain metastases in patients who receive trastuzumab-containing chemotherapy for HER2-overexpressing metastatic breast cancer

Cancer of unknown primary site: review of consecutive cases at the National Cancer Center Hospital of Japan

Clinical efficacy of S-1 in pretreated metastatic breast cancer patients

Clinical outcomes of adult and childhood rhabdomyosarcoma treated with vincristine, d-actinomycin, and cyclophosphamide chemotherapy

Clinicopathological features of tumors as predictors of the efficacy of primary neoadjuvant chemotherapy for operable breast cancer

Comparison among different classification systems regarding the pathological response of preoperative chemotherapy in relation to the long-term outcome

Comparison of dose intensity of vincristine, d-actinomycin, and cyclophosphamide chemotherapy for child and adult rhabdomyosarcoma: a retrospective analysis.

Content analysis of oncology-related pharmaceutical advertising in a peer-reviewed medical journal

Contrasting prognostic implications of platelet-derived growth factor receptor-β and vascular endothelial growth factor receptor-2 in patients with angiosarcoma.

Correlation between human epidermal growth factor receptor 2 expression level and efficacy of trastuzumab beyond progression in metastatic gastric cancer ⬇️

Correlation of p53 and MIB-1 expression with both the systemic recurrence and survival in cases of phyllodes tumors of the breast

Current state of therapeutic development for rare cancers in Japan, and proposals for improvement.

Current trends and controversies over pre-operative chemotherapy for women with operable breast cancer

Depth of response predicts the clinical outcome of advanced HER2-positive gastric cancer to trastuzumab-based first-line chemotherapy

Development and verification of a prediction model using serum tumor markers to predict the response to chemotherapy of patients with metastatic or recurrent breast cancer

Diagnosis of complete response to neoadjuvant chemotherapy using diagnostic imaging in primary breast cancer patients.

Efficacy of Cytotoxic Agents After Progression on Anti-PD-(L)1 Antibody for Pre-treated Metastatic Gastric Cancer

Efficacy of Second-Line Bevacizumab-Containing Chemotherapy for Patients with Metastatic Colorectal Cancer following First-Line Treatment with an Anti-Epidermal Growth Factor Receptor Antibody

Efficacy of everolimus, a novel mTOR inhibitor, against basal-like triple-negative breast cancer cells

Efficacy of taxane regimens in patients with metastatic angiosarcoma

Efficacy of weekly paclitaxel in patients with docetaxel-resistant metastatic breast cancer

Establishment and validation of prognostic nomograms in first-line metastatic gastric cancer patients.

Expression of insulin-like growth factor 1 receptor in primary breast cancer: immunohistochemical analysis

FOLFOX as First-line Therapy for Gastric Cancer with Severe Peritoneal Metastasis

Factors that affect the duration of the interval between the completion of palliative chemotherapy and death

Favorable outcome in patients with breast cancer in the presence of pathological response after neoadjuvant endocrine therapy

Feasibility and usefulness of the 'Distress Screening Program in Ambulatory Care' in clinical oncology practice

Gene expression profiling of ATP-binding cassette (ABC) transporters as a predictor of the pathologic response to neoadjuvant chemotherapy in breast cancer patients

Genetic testing for effective Herceptin therapy

Hematologic safety of breast cancer chemotherapies in patients with hepatitis B or C virus infection

Immunohistochemical expression of HER1, HER3, and HER4 in HER2-positive breast cancer patients treated with trastuzumab-containing neoadjuvant chemotherapy

Immunohistochemical expression of PTEN and phosphorylated Akt are not correlated with clinical outcome in breast cancer patients treated with trastuzumab-containing neo-adjuvant chemotherapy

Immunohistochemical profile for unknown primary adenocarcinoma

Influence of suboptimal treatment in patients with mediastinal primary nonseminomatous germ cell tumors

Leptomeningeal metastasis from ovarian carcinoma successfully treated by the intraventricular administration of methotrexate

Long-term outcome and pattern of relapse after neoadjuvant chemotherapy in patients with human epidermal growth factor receptor 2-positive primary breast cancer.

Long-term survival analysis of addition of carboplatin to neoadjuvant chemotherapy in HER2-negative breast cancer

Morphologic Response and Tumor Shrinkage as Early Predictive Markers in Unresectable Colorectal Liver Metastases

Multicenter phase II trial assessing effectiveness of imatinib mesylate on relapsed or refractory KIT-positive or PDGFR-positive sarcoma

Neutropenia as a Predictive Factor in Metastatic Colorectal Cancer Treated With TAS-102

Outpatient management of low-risk febrile patients on paclitaxel and carboplatin for ovarian cancer.

Paclitaxel-induced peripheral neuropathy in patients receiving adjuvant chemotherapy for breast cancer

Phase I Study of Alternate-Day Administration of S-1, Oral Leucovorin, and Bevacizumab for Refractory Metastatic Colorectal Cancer

Phase I and pharmacokinetic study of nab-paclitaxel, nanoparticle albumin-bound paclitaxel, administered weekly to Japanese patients with solid tumors and metastatic breast cancer

Phase I and pharmacokinetic study of trabectedin, a DNA minor groove binder, administered as a 24-h continuous infusion in Japanese patients with soft tissue sarcoma

Phase I and pharmacokinetic study of trastuzumab emtansine in Japanese patients with HER2-positive metastatic breast cancer

Prediction of response and prognostic factors for Ewing family of tumors in a low incidence population

Prediction of response to repeat utilization of anthracycline in recurrent breast cancer patients previously administered anthracycline-containing chemotherapeutic regimens as neoadjuvant or adjuvant chemotherapy

Primary yolk sac tumor of the omentum: a case report and literature review

Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors

Prognostic factors in young Japanese women with breast cancer: prognostic value of age at diagnosis

Questionnaire survey of treatment choice for breast cancer patients with brain metastasis in Japan: results of a nationwide survey by the task force of the Japanese Breast Cancer Society

Randomized phase II study of primary systemic chemotherapy and trastuzumab for operable HER2 positive breast cancer.

Randomized phase II study of weekly paclitaxel with and without carboplatin followed by cyclophosphamide/epirubicin/5-fluorouracil as neoadjuvant chemotherapy for stage II/IIIA breast cancer without HER2 overexpression

Randomized phase III trial of trastuzumab monotherapy followed by trastuzumab plus docetaxel versus trastuzumab plus docetaxel as first-line therapy in patients with HER2-positive metastatic breast cancer: the JO17360 Trial Group

Regorafenib Versus Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: A Retrospective Comparison

Relapse with malignant transformation after chemotherapy for primary mediastinal seminoma: case report.

Safety and efficacy of a combination of docetaxel and cisplatin in patients with unknown primary cancer

Salvage chemotherapy with the combination of oxaliplatin, leucovorin, and 5-fluorouracil in advanced gastric cancer refractory or intolerant to fluoropyrimidines, platinum, taxanes, and irinotecan.

Second platinum therapy in patients with uterine cervical cancer previously treated with platinum chemotherapy

Second-line chemotherapy in patients with primary unknown cancer.

Serum CA19-9 Response Is an Early Predictive Marker of Efficacy of Regorafenib in Refractory Metastatic Colorectal Cancer

Standardization of the body surface area (BSA) formula to calculate the dose of anticancer agents in Japan

Successful Treatment of Cardiac Angiosarcoma Associated with Disseminated Intravascular Coagulation with Nab-Paclitaxel: A Case Report and Review of the Literature

The impact of the Glasgow Prognostic Score on survival in second-line chemotherapy for metastatic colorectal cancer patients with V600E mutation

The incidence and management of metachronous testicular germ cell tumors in patients with extragonadal germ cell tumors

The notorious "drug lag" for oncology drugs in Japan

The outpatient management of low-risk febrile patients with neutropenia: risk assessment over the telephone.

The use of contrast-enhanced computed tomography before neoadjuvant chemotherapy to identify patients likely to be treated safely with breast-conserving surgery